Observational studyThoracic cancer2022

Local consolidative therapy for synchronous oligometastatic non-small cell lung cancer treated with first-line pembrolizumab: A retrospective observational study.

Ya Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.